Company Short-Term Debt: orasure.com (OSUR)

Public company logo of OraSure (OSUR)

OraSure Technologies (OSUR) is establishing a rapid diagnostics environment by combining saliva tests with digital monitoring to combat pandemics. This price chart reflects the asset's dynamics, with a value of 0.00. The company specializes in laboratory research of biomaterials to detect pathologies. The business is currently overcoming a post-pandemic revenue decline, while a lack of debt mitigates financial risks during the implementation of molecular methodologies.

OSUR (OraSure) Company Short-Term Debts history from 07/04/2022 to 10/30/2026

Analytical breakdowns and data insights for company OraSure Corp (OSUR)

- stock price and consensus target price:
Stock Price OraSure|OSUR - Analyst Consensus Forecast
- company stock exchange capitalization indicators:
Market Value OraSure Technologies|OSUR - Business Value
- shareholders' equity book value data:
Book Value per Share OraSure|OSUR - Book Capitalization|Market Value to Book Value Ratio orasure.com|OSUR - Aggregate Company Assets
- debt burden and liquidity indicators:
Total Debt to Equity Ratio OraSure Technologies|OSUR - Long-Term Liabilities to Capital|Short-Term Debt to Equity OraSure Technologies|OSUR - Company Total Debt Obligations|Debts to Book Capitalization OraSure Technologies|OSUR - Long-Term Debt Volume|Company Short-Term Debt OraSure|Quick Liquidity orasure.com
- net income and valuation multiples indicators:
OSUR - Company Net Income
Fundamental company analysis:OraSure (OSUR)
Flagship merchandise of OraSure Technologies

OraSure Technologies (OSUR) relies on stable government demand for rapid diagnostics, which creates a consistent cash flow. This indicator aggregates all credit obligations due for repayment within twelve months. Analyzing this burden allows investors to assess liquidity risk and the issuer's financial autonomy. Controlling borrowings prevents capital erosion amid regulatory inertia. The trend in total short-term debt clearly demonstrates the balance between leverage and operational resilience.

Competitors of OraSure Technologies

Agilent - Company Short-Term Debts|DGX - Company Short-Term Debts|Illumina Corp (ILMN) - Company Short-Term Debt|Company Short-Term Indebtedness EXAS|RVTY (Revvity, Inc.) - Company Short-Term Debts|Company Short-Term Debts bio-rad.com|Company Short-Term Debt Anbio (NNNN)|Company Short-Term Debt SHC (Sotera Health Corp)|QuidelOrtho Corp - Company Current Liabilities|OPKO Health Corp. (OPK) - Short-Term Debt|CDNA - Company Short-Term Debt|Short-Term Debt Volume maravai.com MRVI|FLGT: Company Short-Term Debts|LAB - Short-Term Debt Volume|Company Short-Term Debt Cytek Bio|Exagen Diagnostics (XGN) - Short-Term Debt Volume|Company Short-Term Debt MDxHealth SA (MDXH)|LUCD - Short-Term Debt|Company Short-Term Debt Prenetics PRE|Company Short-Term Loans and Borrowings IMDX|Trinity Biotech Corp - Company Short-Term Debts|PRPH - Company Short-Term Debts|Ainos, Inc. (AIMD) - Company Short-Term Debt|CODX - Short-Term Debt Volume|Company Current Liabilities HSCS|Company Short-Term Debts Biomerica Inc.|Company Short-Term Debt Cardio Diagnostics (CDIO)|VRAX (Virax Biolabs Corp) - Company Short-Term Loans and Borrowings|Company Short-Term Debts BJDX (Bluejay Diagnostics)|aspirawh.com (AWH) - Short-Term Debt|AXDX: Company Current Liabilities|Company Short-Term Loans and Borrowings CNTG (CENTOGENE N.V.)|ENZ (enzo.com) - Company Current Liabilities|FRES: Amount of Current Liabilities|GENE (Genetic Technologies Ltd) - Company Short-Term Debts|Short-Term Debt 23andme.com ME|Company Short-Term Debts PMD